Lee Pitcher MP: written questions

Lee Pitcher MP: full overview

4 Jul 2025–3 Jul 2026

How these years work

Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.

Compare reporting years, sessions and IPSA financial years.

Written questions: dates and coverage

Source checked
15 Nov 2026
Last successful import
15 Nov 2026
Records dated through
13 Nov 2026
Selected period
Reporting year 2: 4 Jul 2025 to 3 Jul 2026
Completeness
Published snapshot: 23,625 records in the source window 17 Aug 2026 to 15 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.

How to read these datesOfficial source

Understand written questions, dates and answers.

Read what this MP said, asked and contributed in Parliament.

79 published records · newest first.

Written questions

  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9210More

    Question: To ask the Secretary of State for Health and Social Care, what evidence the Department has assessed on the number and proportion of patients who develop impulse control disorders while taking dopamine agonists and subsequently (a) continue dopamine agonis

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9209More

    Question: To ask the Secretary of State for Health and Social Care, what data national bodies hold on (a) the number and proportion of people prescribed dopamine agonists who self-report impulse control disorders and (b) the number and proportion whose impulse cont

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9208More

    Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the use of artificial intelligence and digital tools within the NHS and the Medicines and Healthcare products Regulatory Agency to (a) detect potential do

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9207More

    Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the effectiveness of how dopamine agonist-related impulse control disorders and augmentation are taught and assessed in undergraduate medical educat

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9206More

    Question: To ask the Secretary of State for Health and Social Care, whether his Department holds audit or research data on differences between neurology or movement disorder specialists and general practitioners in (a) warning patients and families about dopamine a

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9205More

    Question: To ask the Secretary of State for Health and Social Care, what guidance is issued to clinicians on discussing in advance with patients, and where appropriate their families, how treatment should be managed if severe impulse control disorders develop while

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9204More

    Question: To ask the Secretary of State for Health and Social Care, what assessment the Department has made of the levels of (a) sexually transmitted infections acquired in the context of dopamine agonist-induced hypersexuality and (b) unplanned pregnancies among w

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9203More

    Question: To ask the Secretary of State for Health and Social Care, what data the Department holds on (a) the number and proportion of dopamine agonist-treated patients who report binge eating or marked weight gain, (b) weight and metabolic monitoring practices whe

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9202More

    Question: To ask the Secretary of State for Health and Social Care, what assessment the Department has made of the level of suicides and attempted suicides among (a) people prescribed dopamine agonists who have experienced impulse control disorders, augmentation or

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9201More

    Question: To ask the Secretary of State for Health and Social Care, what data the Department holds on the number and proportion of dopamine agonist-treated patients with impulse control disorders who experience relationship breakdown or divorce.

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9200More

    Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of dopamine agonist-related impulse control disorders and augmentation in people with restless legs syndrome and Parkinson’s disease

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 11 Jun 2026AnsweredUIN 9199More

    Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential financial impact of dopamine agonist-related impulse control disorders on those experiencing such disorders, including through (a) gambling-

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 10 Jun 2026AnsweredUIN 8940More

    Question: To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number and proportion of patients who, having developed impulse control disorders while taking dopamine agonists and attempted withdrawal, subsequently

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 10 Jun 2026AnsweredUIN 8939More

    Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the typical duration and severity of withdrawal symptoms associated with dopamine agonist dose reduction or discontinuation; and how those outcomes vary b

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 10 Jun 2026AnsweredUIN 8938More

    Question: To ask the Secretary of State for Health and Social Care, what data his Department and the Medicines and Healthcare products Regulatory Agency holds on how many and what proportion of patients develop withdrawal symptoms, including dopamine agonist withdr

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 10 Jun 2026AnsweredUIN 8937More

    Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the extent of under-reporting of dopamine agonist-related impulse control disorders to the Yellow Card scheme; and what steps it is taking to improv

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 10 Jun 2026AnsweredUIN 8936More

    Question: To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of patients exposed to dopamine agonists for (a) Parkinson’s disease and (b) restless legs syndrome; and what comparison the Department has made

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Drugs: Side EffectsDepartment of Health and Social CareTabled 10 Jun 2026AnsweredUIN 8935More

    Question: To ask the Secretary of State for Health and Social Care, how many Yellow Card reports have (a) listed pramipexole, ropinirole, rotigotine and cabergoline as a suspected medicine and (b) included any reaction term relating to impulse control disorders, in

    Answer: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...

    Answered 8 Jul 2026

    Original Parliament record
  • Restless Legs Syndrome: DrugsDepartment of Health and Social CareTabled 5 Jun 2026AnsweredUIN 7259More

    Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that patients prescribed dopamine agonists are informed about the risk of impulse control disorders.

    Answer: The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines and healthcare products meet appropriate standards of safety, quality, and effectiveness and are supported by detailed product information, via the P...

    Answered 15 Jun 2026

    Original Parliament record
  • Hospitality Industry: VATTreasuryTabled 4 Jun 2026AnsweredUIN 7081More

    Question: To ask the Chancellor of the Exchequer, if she will make an assessment of the potential merits of extending the Great British Summer Savings scheme to include admission to public swimming pools.

    Answer: From 25 June to 1 September the Government is introducing a temporary reduced rate of VAT on children's menu meals and eligible family attractions. This is a targeted and temporary scheme to reduce the costs of children’s meals in restaurants, children’s ...

    Answered 12 Jun 2026

    Original Parliament record
  • Dementia: Health ServicesDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6554More

    Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people with complex dementia needs, including those requiring one-to-one support, can access safe and suitable care placements following discharge

    Answer: The Government recognises the challenges in securing suitable care placements for people with complex needs including dementia. National Health Service bodies and local authorities are expected to work together to plan discharge early and ensure that care...

    Answered 15 Jun 2026

    Original Parliament record
  • Water: SafetyDepartment for EducationTabled 1 Jun 2026AnsweredUIN 5765More

    Question: To ask the Secretary of State for Education, what steps she is taking to ensure that schoolchildren receive adequate water safety education before the summer holiday period.

    Answer: The PE national curriculum makes specific reference to swimming and water safety, stating that all primary pupils must learn to swim competently and confidently over a distance of at least 25 metres, use a range of strokes effectively and perform safe sel...

    Answered 9 Jun 2026

    Original Parliament record
  • DrowningsCabinet OfficeTabled 1 Jun 2026AnsweredUIN 5764More

    Question: To ask the Minister for the Cabinet Office, how many deaths related to open water swimming have been recorded in England in 2026 to date.

    Answer: The information requested falls under the remit of the UK Statistics Authority.A response to the Hon gentleman’s Parliamentary Question of 1st June is attached.

    Answered 8 Jun 2026

    Original Parliament record
  • Driving LicencesDepartment for TransportTabled 20 May 2026AnsweredUIN 3615More

    Question: To ask the Secretary of State for Transport, what steps she is taking to increase the speed at which the Driver and Vehicle Licensing Agency processes driving licence renewals.

    Answer: The quickest way to transact with the Driver and Vehicle Licensing Agency (DVLA) is by using its online services. The DVLA’s target is to dispatch 95 per cent of straightforward online driving licence applications within three working days and 90 per cent...

    Answered 2 Jun 2026

    Original Parliament record
  • Prison Officers: Industrial DisputesMinistry of JusticeTabled 18 May 2026AnsweredUIN 2493More

    Question: To ask the Secretary of State for Justice, what assessment he has made of the case for restoring the right to strike for prison officers in England and Wales.

    Answer: Prison officers work in difficult environments every day, with some of the most challenging people in society. The Government recognises that the work of prison officers is of critical importance in protecting the public and ensuring the safety and securi...

    Answered 27 May 2026

    Original Parliament record
Explore activity by topic or department

Written questions by answering department

4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.

View as listCabinet Office: 1Cabinet Office1Department for Business and Trade: 1Department for Business and Trade1Department for Culture, Media and Sport: 3Department for Culture, Media a…3Department for Education: 2Department for Education2Department for Energy Security and Net Zero: 1Department for Energy Security …1Department for Environment, Food and Rural Affairs: 1Department for Environment, Foo…1Department for Science, Innovation and Technology: 3Department for Science, Innovat…3Department for Transport: 6Department for Transport6Department for Work and Pensions: 3Department for Work and Pensions3Department of Health and Social Care: 39Department of Health and Social…39Home Office: 3Home Office3Ministry of Defence: 1Ministry of Defence1Ministry of Housing, Communities and Local Government: 8Ministry of Housing, Communitie…8Ministry of Justice: 3Ministry of Justice3Treasury: 4Treasury4
What this shows and doesn't show
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality. Published records do not measure effort or effectiveness. Methodology.
Department or topicPublished records
Cabinet Office1
Department for Business and Trade1
Department for Culture, Media and Sport3
Department for Education2
Department for Energy Security and Net Zero1
Department for Environment, Food and Rural Affairs1
Department for Science, Innovation and Technology3
Department for Transport6
Department for Work and Pensions3
Department of Health and Social Care39
Home Office3
Ministry of Defence1
Ministry of Housing, Communities and Local Government8
Ministry of Justice3
Treasury4

Published records only — not a full account of an MP’s work. How we work →